BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37029417)

  • 21. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.
    Sinha S; Castillo V; Espinoza CR; Tindle C; Fonseca AG; Dan JM; Katkar GD; Das S; Sahoo D; Ghosh P
    bioRxiv; 2022 Jul; ():. PubMed ID: 34873597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative omics approaches and machine-learning strategies.
    Yang F; Wendusubilige ; Kong J; Zong Y; Wang M; Jing C; Ma Z; Li W; Cao R; Jing S; Gao J; Li W; Wang J
    EPMA J; 2023 Sep; 14(3):417-442. PubMed ID: 37605652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YTHDC1 delays cellular senescence and pulmonary fibrosis by activating ATR in an m6A-independent manner.
    Zhang C; Chen L; Xie C; Wang F; Wang J; Zhou H; Liu Q; Zeng Z; Li N; Huang J; Zhao Y; Liu H
    EMBO J; 2024 Jan; 43(1):61-86. PubMed ID: 38177310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic WNT/β-catenin signaling induces cellular senescence in lung epithelial cells.
    Lehmann M; Hu Q; Hu Y; Hafner K; Costa R; van den Berg A; Königshoff M
    Cell Signal; 2020 Jun; 70():109588. PubMed ID: 32109549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis.
    Yao C; Guan X; Carraro G; Parimon T; Liu X; Huang G; Mulay A; Soukiasian HJ; David G; Weigt SS; Belperio JA; Chen P; Jiang D; Noble PW; Stripp BR
    Am J Respir Crit Care Med; 2021 Mar; 203(6):707-717. PubMed ID: 32991815
    [No Abstract]   [Full Text] [Related]  

  • 26. Citrus Alkaline Extracts Inhibit Senescence of A549 Cells to Alleviate Pulmonary Fibrosis via the β-Catenin/P53 Pathway.
    Han D; Xu Y; Peng WP; Feng F; Wang Z; Gu C; Zhou X
    Med Sci Monit; 2021 Mar; 27():e928547. PubMed ID: 33707405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.
    Summer R; Todd JL; Neely ML; Lobo LJ; Namen A; Newby LK; Shafazand S; Suliman S; Hesslinger C; Keller S; Leonard TB; Palmer SM; Ilkayeva O; Muehlbauer MJ; Newgard CB; Roman J
    Respir Res; 2024 Jan; 25(1):58. PubMed ID: 38273290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The senescence-associated matricellular protein CCN1 in plasma of human subjects with idiopathic pulmonary fibrosis.
    Kulkarni T; Kurundkar AR; Kim YI; de Andrade J; Luckhardt T; Thannickal VJ
    Respir Med; 2020 Jan; 161():105821. PubMed ID: 31765873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTEN loss regulates alveolar epithelial cell senescence in pulmonary fibrosis depending on Akt activation.
    Qiu T; Tian Y; Gao Y; Ma M; Li H; Liu X; Wu H; Zhang Y; Ding H; Cao M; Zhang J; Dai J; Chen J; Cai H
    Aging (Albany NY); 2019 Sep; 11(18):7492-7509. PubMed ID: 31527305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive investigation of idiopathic pulmonary fibrosis subtypes based on cellular senescence-related genes for disease treatment and management.
    Yang C; Han Z; Zhan W; Wang Y; Feng J
    Front Genet; 2023; 14():1157258. PubMed ID: 37035748
    [No Abstract]   [Full Text] [Related]  

  • 31. Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?
    Alfaro TM; Robalo Cordeiro C
    Ther Adv Respir Dis; 2020; 14():1753466620910092. PubMed ID: 32167024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hesperidin inhibits lung fibroblast senescence via IL-6/STAT3 signaling pathway to suppress pulmonary fibrosis.
    Han D; Gong H; Wei Y; Xu Y; Zhou X; Wang Z; Feng F
    Phytomedicine; 2023 Apr; 112():154680. PubMed ID: 36736168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of YAP1-gene Knockdown to Inhibit Alveolar-Epithelial-Cell Senescence and Alleviate Idiopathic Pulmonary Fibrosis (IPF).
    Xu W; Song W; Wang YU; Zan Y; Zhang M; Li M; Huang Q; Zhao W; Sun YU; Hoffman RM; Wu J
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):451-459. PubMed ID: 33994367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Proteomics Identifies Biomarkers Associated With the Pathogenesis of Idiopathic Pulmonary Fibrosis.
    Wang L; Zhu M; Li Y; Yan P; Li Z; Chen X; Yang J; Pan X; Zhao H; Wang S; Yuan H; Zhao M; Sun X; Wan R; Li F; Wang X; Yu H; Rosas I; Ding C; Yu G
    Mol Cell Proteomics; 2023 Apr; 22(4):100524. PubMed ID: 36870568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.
    Yan F; Wen Z; Wang R; Luo W; Du Y; Wang W; Chen X
    BMC Pulm Med; 2017 Dec; 17(1):174. PubMed ID: 29212488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary Fibrosis.
    Kalafatis D; Löfdahl A; Näsman P; Dellgren G; Wheelock ÅM; Elowsson Rendin L; Sköld M; Westergren-Thorsson G
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA-PKcs modulates progenitor cell proliferation and fibroblast senescence in idiopathic pulmonary fibrosis.
    Habiel DM; Hohmann MS; Espindola MS; Coelho AL; Jones I; Jones H; Carnibella R; Pinar I; Werdiger F; Hogaboam CM
    BMC Pulm Med; 2019 Aug; 19(1):165. PubMed ID: 31464599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYFRA 21.1 in bronchoalveolar lavage of idiopathic pulmonary fibrosis patients.
    Vercauteren IM; Verleden SE; McDonough JE; Vandermeulen E; Ruttens D; Lammertyn EJ; Bellon H; De Dycker E; Dooms C; Yserbyt J; Verleden GM; Vanaudenaerde BM; Wuyts WA
    Exp Lung Res; 2015; 41(8):459-65. PubMed ID: 26381718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological and molecular analysis of idiopathic pulmonary fibrosis lungs from patients treated with pirfenidone or nintedanib.
    Zhang Y; Jones KD; Achtar-Zadeh N; Green G; Kukreja J; Xu B; Wolters PJ
    Histopathology; 2019 Jan; 74(2):341-349. PubMed ID: 30152895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.